The comparative cardiovascular and renal effectiveness of sodium‐glucose co‐transporter‐2 inhibitors and glucagon‐like peptide‐1 receptor agonists: A Scandinavian cohort studyPeter Ueda, Björn Pasternak|Diabetes Obesity and Metabolism|2021Cited by 31
Sodium-glucose co-transporter 2 inhibitor treatment and risk of atrial fibrillation: Scandinavian cohort studyArvid Engström, Peter Ueda|Unknown|2022Cited by 0